Search Results
Is HER2-low a distinct subtype of breast cancer?
HER2-low is not a distinct subtype in inflammatory breast cancer
The evolution of HER2-low-positive breast cancer as a clinical subtype
Defining HER2-low breast cancer as a clinical subtype
Latest news in HER2-low breast cancer
Questions remaining in the field of HER2-low breast cancer
HER2 Low Breast Cancer A New Therapeutic Subtype | 2023 KU Breast Cancer Year in Review Conference
A New View of the Spectrum of HER2 Expression and Significance of HER2 Low in Breast Cancer
Compelling Teaching Cases Focused on the Management of Metastatic Breast Cancer
Clinical and molecular characteristics of HER2-low/zero early stage triple-negative breast cancer
Clinical outcomes in women with metastatic HER2-low breast cancer in the real world
The exciting new field of HER2-low breast cancer
